Mn Services Vermogensbeheer B.V. Sells 15,600 Shares of Aflac Incorporated (NYSE:AFL)

Mn Services Vermogensbeheer B.V. decreased its holdings in Aflac Incorporated (NYSE:AFL - Free Report) by 7.1% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 202,600 shares of the financial services provider's stock after selling 15,600 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in Aflac were worth $22,527,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Brighton Jones LLC raised its stake in shares of Aflac by 64.4% in the 4th quarter. Brighton Jones LLC now owns 14,570 shares of the financial services provider's stock worth $1,507,000 after buying an additional 5,708 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Aflac by 39.9% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 64,399 shares of the financial services provider's stock valued at $6,592,000 after purchasing an additional 18,366 shares during the last quarter. WASHINGTON TRUST Co boosted its holdings in Aflac by 4.4% during the fourth quarter. WASHINGTON TRUST Co now owns 4,735 shares of the financial services provider's stock worth $490,000 after buying an additional 200 shares in the last quarter. Next Level Wealth Planning LLC acquired a new position in Aflac in the fourth quarter worth approximately $318,000. Finally, Principal Securities Inc. increased its holdings in shares of Aflac by 2.9% in the fourth quarter. Principal Securities Inc. now owns 14,511 shares of the financial services provider's stock valued at $1,501,000 after buying an additional 407 shares in the last quarter. 67.44% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction on Thursday, May 8th. The shares were sold at an average price of $106.79, for a total value of $106,790.00. Following the completion of the sale, the director now directly owns 26,096 shares of the company's stock, valued at $2,786,791.84. This represents a 3.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Masatoshi Koide sold 37,000 shares of Aflac stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total value of $3,906,830.00. Following the sale, the director now directly owns 70,992 shares in the company, valued at $7,496,045.28. The trade was a 34.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 40,750 shares of company stock worth $4,304,295 in the last 90 days. 0.80% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

AFL has been the topic of a number of analyst reports. UBS Group lifted their price target on Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 2nd. Barclays lifted their target price on shares of Aflac from $95.00 to $96.00 and gave the stock an "underweight" rating in a research report on Thursday, May 1st. Wells Fargo & Company boosted their price target on shares of Aflac from $102.00 to $103.00 and gave the company an "equal weight" rating in a report on Tuesday, May 6th. Morgan Stanley raised their target price on Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a research report on Monday, May 19th. Finally, Piper Sandler raised their price objective on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Aflac currently has an average rating of "Hold" and an average price target of $104.93.

Aflac Stock Down 0.6%

Shares of AFL stock traded down $0.64 on Tuesday, hitting $102.08. The company's stock had a trading volume of 2,056,898 shares, compared to its average volume of 2,113,644. The stock has a market capitalization of $55.19 billion, a price-to-earnings ratio of 14.25, a P/E/G ratio of 3.18 and a beta of 0.82. The firm's fifty day moving average price is $105.15 and its 200-day moving average price is $105.39. Aflac Incorporated has a fifty-two week low of $87.68 and a fifty-two week high of $115.50. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The company had revenue of $3.40 billion for the quarter, compared to analyst estimates of $4.53 billion. During the same quarter last year, the business earned $1.66 EPS. The company's revenue for the quarter was down 37.5% on a year-over-year basis. Research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were given a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a yield of 2.27%. The ex-dividend date of this dividend was Wednesday, May 21st. Aflac's dividend payout ratio is 36.25%.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.